Topic · page 114 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 4,521–4,560 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

Diabetes Obes Metab9 Jan 2023
Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes
Research article
Diabetes Res Clin Pract8 Jan 2023
Hospitalisation for mental health disorders in Australians with type 1 or type 2 diabetes
Cohort study
Endocr Pract7 Jan 2023
Trends in Cardiovascular Risk Factors by Income Among Japanese Adults Aged 30-49 Years From 2017 to 2020: A Nationwide Longitudinal Cohort Study
Cohort study
Diabetes Res Clin Pract7 Jan 2023
Longitudinal trends in glycated hemoglobin during and after tuberculosis treatment
Cohort study
J Clin Endocrinol Metab7 Jan 2023
Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients
Cohort study
Cardiovasc Diabetol6 Jan 2023
Risk of heart failure in elderly patients with atrial fibrillation and diabetes taking different oral anticoagulants: a nationwide cohort study
Cohort study
Diabetes Care6 Jan 2023
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden
Cohort study
Diabetes Res Clin Pract6 Jan 2023
Fasting stress hyperglycemia ratio and in-hospital mortality after acute myocardial infarction in patients with different glucose metabolism status: Results from China acute myocardial infarction registry
Cohort study
Diabet Med6 Jan 2023
Developments in the design and delivery of self‐management support for children and young people with diabetes: A narrative synthesis of systematic reviews
Research article
Diabet Med6 Jan 2023
‘We tend to prioritise others and forget ourselves’: How women's caregiving responsibilities can facilitate or impede diabetes self‐management
Secondary analysis
J Diabetes Sci Technol5 Jan 2023
Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes: Rationale and Design of a Randomized Controlled Trial
Trial design
Diabetes Res Clin Pract5 Jan 2023
Association between arterial stiffness/remodeling and new-onset type 2 diabetes mellitus in general population
Cohort study
Diabetes Res Clin Pract5 Jan 2023
Effect of sodium-glucose co-transporter 2 inhibitors on plasma potassium: A meta-analysis
Meta-analysis
Diabetes Res Clin Pract5 Jan 2023
Risk factors of dapagliflozin-associated diabetic ketosis/ketoacidosis in patients with type 2 diabetes mellitus: A matched case-control study
Case-control study
Diabetes Res Clin Pract4 Jan 2023
Opioid prescription and diabetes among Medicare beneficiaries
Cohort study
Diabetes Metab3 Jan 2023
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Cohort study
BMJ Open Diabetes Res Care3 Jan 2023
Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK
Cohort study
JAMA Netw Open3 Jan 2023
Association of Sodium-Glucose Cotransporter 2 Inhibitor vs Dipeptidyl Peptidase-4 Inhibitor Use With Risk of Incident Obstructive Airway Disease and Exacerbation Events Among Patients With Type 2 Diabetes in Hong Kong
Cohort study
Diabetes Obes Metab3 Jan 2023
Changes in the use of glucose‐lowering drugs: A Danish nationwide study
Cohort study
JAMA Netw Open3 Jan 2023
Continuity of Medication Use by US Adults With Diabetes, 2005-2019
Cross-sectional study
JAMA Netw Open3 Jan 2023
Evaluation of High-Deductible Health Plans and Acute Glycemic Complications Among Adults With Diabetes
Cohort study
Diabetes Obes Metab3 Jan 2023
Impact of a multicomponent healthcare intervention on glycaemic control in subjects with poorly controlled type 2 diabetes: The INTEGRA study
Randomized controlled trial
JAMA Netw Open3 Jan 2023
Prevalence of Undiagnosed Diabetes Identified by a Novel Electronic Medical Record Diabetes Screening Program in an Urban Emergency Department in the US
Cross-sectional study
Diabetes Obes Metab3 Jan 2023
Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial
Secondary analysis
Lancet Diabetes EndocrinolJanuary 2023
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials
Randomized controlled trial
J Clin Endocrinol Metab27 Dec 2022
Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients With Type 2 Diabetes
Cohort study
Diabetes Obes Metab27 Dec 2022
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS ‐1 to ‐5 studies
Secondary analysis
Diabetes Obes Metab27 Dec 2022
Age‐dependent prevalence of type 2 diabetes, cardiovascular risk profiles and use of diabetes drugs in Germany using health claims data
Cross-sectional study
Diabetes Obes Metab27 Dec 2022
Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis
Research article
Diabetes Res Clin Pract26 Dec 2022
Disparities in adoption of new diabetic therapies with cardiovascular benefits
Cohort study
Diabetes Obes Metab26 Dec 2022
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV , a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin
Secondary analysis
J Diabetes Sci Technol23 Dec 2022
Time for Using Machine Learning for Dose Guidance in Titration of People With Type 2 Diabetes? A Systematic Review of Basal Insulin Dose Guidance
Meta-analysis
Diabet Med23 Dec 2022
Management of adults with diabetes on dialysis: Summary of recommendations of the Joint British Diabetes Societies guidelines 2022
Guideline or statement
J Clin Endocrinol Metab22 Dec 2022
Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study
Cohort study
J Clin Endocrinol Metab22 Dec 2022
Accumulation in Visceral Adipose Tissue Over 6 Years Is Associated With Lower Paraspinal Muscle Density
Cohort study
Diabetes Obes Metab22 Dec 2022
Safety, tolerability, pharmacodynamics and pharmacokinetics following once‐daily doses of BI 187004, an inhibitor of 11 beta‐hydroxysteroid dehydrogenase‐1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity
Randomized controlled trial
Diabetes Care21 Dec 2022
An Examination of Whether Diabetes Control and Treatments Are Associated With Change in Frailty Index Across 8 Years: An Ancillary Exploratory Study From the Action for Health in Diabetes (Look AHEAD) Trial
Secondary analysis
Diabetes Care21 Dec 2022
Different Types of Industry-Produced and Ruminant Trans Fatty Acid Intake and Risk of Type 2 Diabetes: Findings From the NutriNet-Santé Prospective Cohort
Cohort study
Diabetes Res Clin Pract21 Dec 2022
Relationship between intra-individual variability in nutrition-related lifestyle behaviors and blood glucose outcomes under free-living conditions in adults without type 2 diabetes
Cohort study
Diabet Med21 Dec 2022
Management of Hyperosmolar Hyperglycaemic State (HHS) in Adults: An updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group
Guideline or statement

All 4,758 Briefs in ExploreShowing Briefs 4,521–4,560 of 4,758, newest first